Clinicopathological Features of KRAS-Mutated Colon Cancer: An Analytical Cross-Sectional Study
KRAS-positive patients predominantly had tumors in the sigmoid colon. The coexistence of <i>KRAS</i> and <i>BRAF</i> mutations suggests a potential molecular interaction influencing disease progression. These findings highlight a distinct genomic pattern and the need for further research into its clinical implications.
Authors
- Alejandro González‐Ojeda (ORCID: https://orcid.org/0000-0003-2935-8703)
- Edgar J. Cortes-Torres (ORCID: https://orcid.org/0000-0002-0430-2888)
- Sara Vázquez‐Sánchez (ORCID: https://orcid.org/0000-0002-8082-9745)
- Clotilde Fuentes‐Orozco (ORCID: https://orcid.org/0000-0001-6230-8359)
- Helí Hernandez-González
- Andrea García (ORCID: https://orcid.org/0009-0005-5301-7556)
- Samantha Emily González-Muñoz (ORCID: https://orcid.org/0009-0001-2404-891X)
- Kathia Dayana Morfín-Meza (ORCID: https://orcid.org/0009-0003-5386-6641)
- Carlos Enrique Capetillo-Texson
- José Pablo Gómez-Sierra
- Xóchitl Monteón-Aspeitia
- Vianney Teresita Hernández-Ramirez
- Alejandro Ruben Villasenor-Rodriguez
Institutions
- Universidad de Colima (MX)
Publication Details
- Journal
- Gastroenterology Research
- Published
- 2025-07-05
- DOI
- https://doi.org/10.14740/gr2032
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00